Collaborations

Genaissance enters pharmacogenomics agreement

Published in Health and Medicine Week, January 5th, 2004

Genaissance Pharmaceuticals, Inc., (GNSC) has entered into an agreement with Ferring Pharmaceuticals, A/S, under which Genaissance will provide certain pharmacogenomic services and technology to Ferring.

Under the agreement, Genaissance will provide to Ferring pharmacogenomic expertise including GLP-compliant DNA banking services through its Morrisville, North Carolina, operations.

Genaissance will also collaborate with Ferring to identify clinical projects for the application of Genaissance's HAP Technology.

"We are pleased to be working with Ferring Pharmaceuticals. Ferring holds a global leadership position in key therapeutic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2004-01-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry